NEW YORK (GenomeWeb) – Genetic testing firm Color Genomics today launched with a $15 million private financing round and a $249 test for genes associated with breast and ovarian cancer. 

Based in Burlingame,Calif., the company said that it has begun offering the Color Test, a clinical-grade, comprehensive genetic sequencing test that analyzes 19 genes, including BRCA1 and BRCA2. Other genes on the panel include BARD1, PTEN, CDH1, and ATM, according to Color Genomics' website. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.